Standard InChI: InChI=1S/C13H20Cl2OTe/c1-4-5-10-17(14,15)13-9-7-6-8-12(13)11(2)16-3/h6-9,11H,4-5,10H2,1-3H3/t11-/m1/s1
Standard InChI Key: LTHFOAIQCMDGKN-LLVKDONJSA-N
Associated Targets(Human)
Cathepsin L2 273 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Cathepsin S 3285 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HT-144 176 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HUVEC 11049 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HeLa 62764 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MeWo 235 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
A2058 690 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
SK-MEL-28 48833 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
SK-MEL-25 55 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Cathepsin L 3852 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Cathepsin B 3822 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
B16F10Nex2 30 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
NIH3T3 5395 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 390.81
Molecular Weight (Monoisotopic): 391.9953
AlogP:
#Rotatable Bonds:
Polar Surface Area:
Molecular Species:
HBA:
HBD:
#RO5 Violations:
HBA (Lipinski):
HBD (Lipinski):
#RO5 Violations (Lipinski):
CX Acidic pKa:
CX Basic pKa:
CX LogP:
CX LogD:
Aromatic Rings:
Heavy Atoms:
QED Weighted:
Np Likeness Score:
References
1.Piovan L, Alves MF, Juliano L, Brömme D, Cunha RL, Andrade LH.. (2011) Structure-activity relationships of hypervalent organochalcogenanes as inhibitors of cysteine cathepsins V and S., 19 (6):[PMID:21345684][10.1016/j.bmc.2011.01.054]
2.Piovan L, Milani P, Silva MS, Moraes PG, Demasi M, Andrade LH.. (2014) 20S proteasome as novel biological target for organochalcogenanes., 73 [PMID:24463395][10.1016/j.ejmech.2013.12.011]
3.Paschoalin T, Martens AA, Omori ÁT, Pereira FV, Juliano L, Travassos LR, Machado-Santelli GM, Cunha RLOR.. (2019) Antitumor effect of chiral organotelluranes elicited in a murine melanoma model., 27 (12):[PMID:30962115][10.1016/j.bmc.2019.03.032]